Remdesivir for Hospitalized COVID-19 Patients in the United States: Optimization of Health Care Resources
Description
CONCLUSIONS: Remdesivir + SOC alone represents a cost-effective treatment for hospitalized patients with COVID-19. This analysis can aid in future decisions on the allocation of healthcare resources.
